Kno2’s Pursuit for QHIN Designation

Ezra Mehlman is a Managing Partner at Health Enterprise Partners, a HCIT and services-focused growth equity firm whose investors include some of the largest health systems and health plans across the country.

Ezra joined HEP in 2010, while completing his MBA at Columbia Business School. Prior to joining the team, Ezra was a Senior Analyst at the Advisory Board Company (NASDAQ: ABCO), providing best practice consulting and research services to hospitals and health systems. After leaving the Advisory Board Company, Ezra served as a Senior Consultant in the health care practice of Booz Allen Hamilton focusing on engagements in the provider space.

Ezra is currently on the board of directors of Wildflower Health, Kno2, and Jvion. He previously served on the board of directors AxiaMed (acquired by Bank of America), Applied Pathways (acquired by AIM Specialty Health, a division of Anthem, Inc), CenterPointe Behavioral Health System (aquired by Acadia Healthcare), InDemand Interpreting (acquired by Stratus Video/AMN Healthcare) and Twistle (aquired by Health Catalyst). He sits on the Harvard School of Public Health’s Health Policy and Management Executive Council. He is on the faculty of Columbia Business School.

Ezra holds a BA cum laude from Washington University in St. Louis, and an MBA from Columbia Business School.